Results 171 to 180 of about 8,230 (206)
Some of the next articles are maybe not open access.

Multiple Colorectal Neoplasms in X-Linked Agammaglobulinemia

Clinical Gastroenterology and Hepatology, 2008
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder caused by germline mutation of the Bruton tyrosine kinase (BTK) gene. It is characterized by disturbed B-cell development, decreased immunoglobulin levels, and increased patient susceptibility to infection.
Brosens, Lodewijk A. A.   +7 more
openaire   +3 more sources

Colocalization of X-Linked Agammaglobulinemia and X-Linked Immunodeficiency Genes

Science, 1993
Mice that bear the X-linked immunodeficiency ( xid ) mutation have a B lymphocyte-specific defect resulting in an inability to make antibody responses to polysaccharide antigens. A backcross of 1114 progeny revealed the colocalization of xid with Bruton's agammaglobulinemia tyrosine kinase (
J D, Thomas   +5 more
openaire   +2 more sources

Genotype/phenotype correlations in X-linked agammaglobulinemia

Clinical Immunology, 2006
No clear genotype/phenotype correlations have been established in patients with X-linked agammaglobulinemia (XLA). To determine if the specific mutation in Btk might be one of the factors that influences the severity of disease or if polymorphic variants in Tec, a cytoplasmic tyrosine kinase that might substitute for Btk, could contribute to the ...
Arnon, Broides   +2 more
openaire   +2 more sources

[X-linked agammaglobulinemia: an update].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004
X-linked agammaglobulinemia (X-LA) was the first described and remains the most common inherited antibody deficiency. Although initially reported by Bruton in early fifties, full clinical picture and detailed pathogenesis were established recently. X-LA was the first immunodeficiency to be mapped to a specific locus in the human genome based on linkage
Rafał, Pawliczak, Marek L, Kowalski
openaire   +2 more sources

Progressive Encephalopathy Associated with X-Linked Agammaglobulinemia

European Neurology, 1982
Bruton type agammaglobulinemia is an X-linked disease with humoral immunological deficiency. Children with congenital agammaglobulinemia develop bacterial infections easily.
T. Sacquegna   +7 more
openaire   +3 more sources

X‐linked agammaglobulinemia complicated with endobronchial tuberculosis

Acta Paediatrica, 2010
AbstractAim:  We report a case of X‐linked agammaglobulinemia complicated with endobronchial tuberculosis.Methods:  We observed the patient’s clinical course and analysed his data retrospectively.Results: Interestingly, the T‐cell proliferation activity in this patient was intact, and the CD4‐positive T cells produced interferon gamma.
Chihiro, Kawakami   +5 more
openaire   +2 more sources

Maternal germinal mosaicism of X‐linked agammaglobulinemia

American Journal of Medical Genetics, 2001
X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by abnormalities in tyrosine kinase (BTK), and is characterized by a deficiency of peripheral blood B cells. We studied cytoplasmic expression of BTK protein and analyzed the BTK gene (BTK) in peripheral blood mononuclear cells from two siblings with XLA and additional family members ...
M, Sakamoto   +5 more
openaire   +2 more sources

X-Linked Agammaglobulinemia and Bruton’s Tyrosine Kinase

1994
The genetic defect associated with human X-linked agammaglobulinemia (XLA) and murine X-linked immunodeficiency (XID) was recently identified as the deficiency of function of a new cytoplasmic tyrosine kinase called Bruton’s tyrosine kinase (Btk)1,2,3,4. The phenotypes associated with these immunodeficiencies indicate that Btk plays a crucial role in B
S, Tsukada, O N, Witte
openaire   +2 more sources

X-linked agammaglobulinemia

2023
Domenico Nicoletti   +2 more
openaire   +1 more source

Atypical X-linked agammaglobulinemia - reply

1994
To the Editor: The letter of Kornfeld et al. raises two separate questions: Do some patients with mild hypogammaglobulinemia have defects in the same gene as patients with typical X-linked agammaglobulinemia? Can you predict the clinical phenotype of X-linked agammaglobulinemia on the basis of the site of the Btk mutation?
Parolini, Ornella, Rohrer, J, Conley, Me
openaire   +1 more source

Home - About - Disclaimer - Privacy